Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$225.9M
+28.4% from 2023
Prescriptions
19K
$12,086.21 per claim
Patients
3,946
3,190 prescribers
Total spending, 2024
$225.9M
$57,251.76 per patient
Medicare prescription drug plans paid $225.9M for Lonsurf in 2024, for 18,692 prescriptions and refills to 3,946 patients (up 28.4% from 2023). The average cost per claim was $12,086.21.
California had the highest Medicare cost for Lonsurf in 2024: $28.5M for 2,471 claims, followed by New York ($18.4M).
Jessica L Fernandez, physician assistant in Morristown, NJ, had the highest Medicare cost for Lonsurf in 2024: 65 claims costing $757K.
Lonsurf is made by Otsuka Holdings Co., Ltd. (4578.T), listed in the Medicare spending data as Taiho Oncology.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jessica L Fernandez Morristown, NJ | Physician Assistant | 65 | Under 11 | $757K |
| Syed M Kazmi Dallas, TX | Hematology-Oncology | 85 | Under 11 | $718K |
| Aaron J Scott |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,334 | 11,388 | 2,710 | $142.4M |
| 2023 | 2,684 | 13,805 | 3,217 | $175.9M |
| 2024 | 3,190 | 18,692 | 3,946 | $225.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 77 |
| 11 |
| $692K |
| Marwan G Fakih Duarte, CA | Medical Oncology | 42 | Under 11 | $606K |
| Agustin Pimentel Miami, FL | Hematology-Oncology | 33 | Under 11 | $568K |
| Solalba Bueno-Orengo Dorado, PR | Hematology-Oncology | 54 | Under 11 | $550K |
| Todd D Shenkenberg Harlingen, TX | Medical Oncology | 51 | Under 11 | $547K |
| John C Allen Oxford, MS | Hematology-Oncology | 52 | Under 11 | $539K |
| Jose M Tongol Albany, GA | Hematology-Oncology | 50 | Under 11 | $495K |
| Jaswinder Singh Kansas City, MO | Hematology-Oncology | 40 | Under 11 | $484K |
| Aftab Mahmood Corpus Christi, TX | Medical Oncology | 45 | Under 11 | $477K |
| Ira S Wollner Detroit, MI | Medical Oncology | 42 | Under 11 | $474K |
| Rony M Abou-Jawde St Joseph, MO | Hematology-Oncology | 26 | Under 11 | $466K |
| Edward W Greeno Minneapolis, MN | Hematology-Oncology | 21 | Under 11 | $444K |
| Ashvini Sengar Gadsden, AL | Hematology-Oncology | 47 | Under 11 | $436K |
| Ray Page Weatherford, TX | Medical Oncology | 26 | Under 11 | $426K |
| Putao Cen Houston, TX | Medical Oncology | 35 | Under 11 | $403K |
| Fadi S Braiteh Las Vegas, NV | Medical Oncology | 23 | Under 11 | $402K |
| Ahmed Zakari Altamonte Springs, FL | Hematology-Oncology | 32 | Under 11 | $400K |
| Chloe Atreya San Francisco, CA | Medical Oncology | 43 | Under 11 | $399K |
| Sang Hoon AHN Fullerton, CA | Hematology-Oncology | 41 | Under 11 | $397K |
| Mayur D Mody Calhoun, GA | Hospitalist | 19 | Under 11 | $396K |
| Bilal Ansari Mishawaka, IN | Medical Oncology | 32 | Under 11 | $394K |
| Joseph P Yoe New York, NY | Hematology-Oncology | 22 | Under 11 | $391K |
| Sameer Gupta Bryn Mawr, PA | Hematology-Oncology | 21 | Under 11 | $389K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Taiho Oncology 4578.T | 18,692 | $225.9M |